Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideyuki Harada

Showing results (91-100 of 160) with videos related to

Pageof 16
Sort By:
Journal of Radiation Research|May 3, 2023
Clinical results of proton beam radiotherapy for inoperable stage III non-small cell lung cancer: a Japanese national registry studyHitoshi Tatebe, Hideyuki Harada, Keita Mori, et al.
Cytoskeleton (Hoboken, N.J.)|July 28, 2025
Dpcd Induces Hydrocephalus Because of Partial Defects in the Inner Dynein Arms, With Abnormal Ciliary MotilityTaiki Yamamoto, Kazuhito Takeuchi, Yuichi Nagata, et al.
BMC Cancer|August 2, 2024
The indication of palliative whole-brain radiotherapy for patients with brain metastases: a simple prognostic scoring system in the era of stereotactic radiosurgeryToshiaki Hirose, Shoichi Deguchi, Kazuaki Yasui, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 11, 2021
Gefitinib With Concurrent Thoracic Radiotherapy in Unresectable Locally Advanced NSCLC With EGFR Mutation; West Japan Oncology Group 6911LHiroaki Akamatsu, Haruyasu Murakami, Hideyuki Harada, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Randomized phase II trial of weekly dose-intensive chemotherapy or amrubicin plus cisplatin chemotherapy following induction chemoradiotherapy for limited-disease small cell lung cancer (JCOG1011)Ikuo Sekine, Hideyuki Harada, Noboru Yamamoto, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 23, 2025
Clinical outcomes of proton beam therapy for inoperable stage I-IIA non-small cell lung cancer: Japanese nationwide registry studyMasaki Nakamura, Kazushi Maruo, Masao Murakami, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 24, 2026
Response to "Reconsidering 'photon-ineligible' status in concurrent chemo-proton therapy for stage III non-small cell lung cancer"Hiromitsu Iwata, Masao Murakami, Kazushi Maruo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 28, 2025
Long-term outcomes of concurrent chemo-proton therapy for unresectable stage III non-small cell lung cancer: a Japanese national registry studyHiromitsu Iwata, Masao Murakami, Kazushi Maruo, et al.
International Journal of Clinical Oncology|March 19, 2022
Multi-institutional feasibility study of intensity-modulated radiotherapy with chemotherapy for locally advanced non-small cell lung cancerHideyuki Harada, Shota Omori, Keita Mori, et al.
Journal of Radiation Research|October 16, 2025
Inter-institutional variability in CT-to-mass-density conversion tables for helical tomotherapy: a national survey in JapanShogo Tsunemine, Shuichi Ozawa, Ryosei Nakada, et al.
Pageof 16

Showing results (91-100 of 160) with videos related to

Sort By:
Pageof 16
Journal of Radiation Research|May 3, 2023
Clinical results of proton beam radiotherapy for inoperable stage III non-small cell lung cancer: a Japanese national registry studyHitoshi Tatebe, Hideyuki Harada, Keita Mori, et al.
Cytoskeleton (Hoboken, N.J.)|July 28, 2025
Dpcd Induces Hydrocephalus Because of Partial Defects in the Inner Dynein Arms, With Abnormal Ciliary MotilityTaiki Yamamoto, Kazuhito Takeuchi, Yuichi Nagata, et al.
BMC Cancer|August 2, 2024
The indication of palliative whole-brain radiotherapy for patients with brain metastases: a simple prognostic scoring system in the era of stereotactic radiosurgeryToshiaki Hirose, Shoichi Deguchi, Kazuaki Yasui, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 11, 2021
Gefitinib With Concurrent Thoracic Radiotherapy in Unresectable Locally Advanced NSCLC With EGFR Mutation; West Japan Oncology Group 6911LHiroaki Akamatsu, Haruyasu Murakami, Hideyuki Harada, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Randomized phase II trial of weekly dose-intensive chemotherapy or amrubicin plus cisplatin chemotherapy following induction chemoradiotherapy for limited-disease small cell lung cancer (JCOG1011)Ikuo Sekine, Hideyuki Harada, Noboru Yamamoto, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 23, 2025
Clinical outcomes of proton beam therapy for inoperable stage I-IIA non-small cell lung cancer: Japanese nationwide registry studyMasaki Nakamura, Kazushi Maruo, Masao Murakami, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 24, 2026
Response to "Reconsidering 'photon-ineligible' status in concurrent chemo-proton therapy for stage III non-small cell lung cancer"Hiromitsu Iwata, Masao Murakami, Kazushi Maruo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 28, 2025
Long-term outcomes of concurrent chemo-proton therapy for unresectable stage III non-small cell lung cancer: a Japanese national registry studyHiromitsu Iwata, Masao Murakami, Kazushi Maruo, et al.
International Journal of Clinical Oncology|March 19, 2022
Multi-institutional feasibility study of intensity-modulated radiotherapy with chemotherapy for locally advanced non-small cell lung cancerHideyuki Harada, Shota Omori, Keita Mori, et al.
Journal of Radiation Research|October 16, 2025
Inter-institutional variability in CT-to-mass-density conversion tables for helical tomotherapy: a national survey in JapanShogo Tsunemine, Shuichi Ozawa, Ryosei Nakada, et al.
Pageof 16